Ionis (IONS) EVP & GC Patrick O'Neil Buys 63 Shares

What Happened
Patrick R. O'Neil, EVP, CLO & General Counsel of Ionis Pharmaceuticals (IONS), acquired 63 shares on August 31, 2026 at $51.31 per share, a total reported value of approximately $3,232. The transaction was an acquisition under the company’s Employee Stock Purchase Plan (ESPP), and represents a purchase (insider buy).

Key Details

• Transaction date: August 31, 2026; filed with the SEC on September 2, 2026.
• Price and amount: 63 shares at $51.31 per share; total ≈ $3,232.
• Transaction code: reported as "J" (other acquisition) and described in the filing as ESPP purchase.
• Shares owned after transaction: not specified in the summary provided in this request.
• Footnote: Shares purchased under the Ionis Amended and Restated 2000 Employee Stock Purchase Plan; these shares may not be sold until February 28, 2027.
• Timeliness: Form 4 filed two days after the transaction date (appears timely under the two-business-day reporting rule).

Context
This was a straightforward ESPP purchase—employees (including insiders) commonly acquire small amounts through such plans. The monetary value is modest (~$3.2k), and the shares are subject to a holding restriction until Feb 28, 2027 per the filing footnote. As always, purchases show insider buying but do not, by themselves, prove company outlook or future performance.